Publications | Lucence 4/8

top of page

Publications

Filter by:

Amplicon‐Based Liquid Biopsy Platform Complements Tissue Genotyping in Detection of Guideline‐Recommended Biomarkers in Metastatic NSCLC

Publications

2022年10月20日

Amplicon‐Based Liquid Biopsy Platform Complements Tissue Genotyping in Detection of Guideline‐Recommended Biomarkers in Metastatic NSCLC

Amplicon‐Based Liquid Biopsy Platform Complements Tissue Genotyping in Detection of Guideline‐Recommended Biomarkers in Metastatic NSCLC

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers—Analytical validation and performance evaluation with clinical samples

Publications

2022年9月21日

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers—Analytical validation and performance evaluation with clinical samples

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers—Analytical validation and performance evaluation with clinical samples

Sensitive Detection of Lung Cancer Using a Multiomic Plasma Cell-Free DNA Sequencing Assay

Publications

2022年9月1日

Sensitive Detection of Lung Cancer Using a Multiomic Plasma Cell-Free DNA Sequencing Assay

Sensitive Detection of Lung Cancer Using a Multiomic Plasma Cell-Free DNA Sequencing Assay

Peripheral T-Cell Receptor Repertoire Profiling in Non-small Cell Lung Cancer Using an Amplicon-Based Sequencing Assay

Publications

2022年9月1日

Peripheral T-Cell Receptor Repertoire Profiling in Non-small Cell Lung Cancer Using an Amplicon-Based Sequencing Assay

Peripheral T-Cell Receptor Repertoire Profiling in Non-small Cell Lung Cancer Using an Amplicon-Based Sequencing Assay

Retrospective Analysis of BRCA1/2 Alterations in Advanced NSCLC Using An Amplicon-based NGS Liquid Biopsy Assay

Publications

2022年9月1日

Retrospective Analysis of BRCA1/2 Alterations in Advanced NSCLC Using An Amplicon-based NGS Liquid Biopsy Assay

Retrospective Analysis of BRCA1/2 Alterations in Advanced NSCLC Using An Amplicon-based NGS Liquid Biopsy Assay

Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.

Publications

2022年6月2日

Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.

Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.

Early detection of cancer using cell-free DNA (cfDNA) size analysis on a multiplexed amplicon-based next-generation sequencing (NGS) platform.

Publications

2022年6月2日

Early detection of cancer using cell-free DNA (cfDNA) size analysis on a multiplexed amplicon-based next-generation sequencing (NGS) platform.

Early detection of cancer using cell-free DNA (cfDNA) size analysis on a multiplexed amplicon-based next-generation sequencing (NGS) platform.

A cell-free RNA-based next-generation sequencing (NGS) assay for the detection of actionable gene fusions in non-small cell lung cancer (NSCLC) patients.

Publications

2022年6月2日

A cell-free RNA-based next-generation sequencing (NGS) assay for the detection of actionable gene fusions in non-small cell lung cancer (NSCLC) patients.

A cell-free RNA-based next-generation sequencing (NGS) assay for the detection of actionable gene fusions in non-small cell lung cancer (NSCLC) patients.

Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA

Publications

2022年4月29日

Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA

Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA

1

/

8

bottom of page